Today's Rundown Featured Story | | | Thursday, May 21, 2020 Only days after Moderna reported positive early results for its potential COVID-19 vaccine, AstraZeneca has stolen the spotlight back. On Thursday, the U.K. drug giant scored a $1 billion contribution from the United States for development, production and delivery of its potential shot starting this fall. |
|
|---|
|
Top Stories Thursday, May 21, 2020 CVS Health is expanding COVID-19 rapid testing sites to 14 states with the goal of processing up to 1.5 million tests per month. Find out how the retail and pharmacy giant plans to help increase testing sites to multicultural populations that have been hit particularly hard by the epidemic. Thursday, May 21, 2020 A recent survey found a majority of consumers have already or plan to delay getting healthcare due to the COVID-19 pandemic as hospitals and clinics struggle financially. Thursday, May 21, 2020 Before Phlow CEO Eric Edwards was launched into the spotlight earlier this week for a lucrative COVID-19 contract he signed with BARDA, he was best known for pricing controversies at his previous company, Kaléo. But that shouldn't overshadow Phlow's promise to provide low-cost drugs to address the pandemic, says Martin VanTrieste, CEO of Civica Rx, a partner in the new effort. Monday, May 11, 2020 As the COVID-19 pandemic continues, the relationship between pharma sales reps and physicians is starting to settle into a new normal. Digital interactions are on the rise, and doctors are increasingly welcoming contact with reps, according to ongoing polling from healthcare consultancy ZoomRx. Thursday, May 21, 2020 AstraZeneca snared more than $1 billion in U.S. funding to develop and supply the Oxford University vaccine. China's CanSino Bio partners with Precision NanoSystems to work on an mRNA liqid nanoparticle vaccine. GlaxoSmithKline teamed up with Mammoth Biosciences to develop a CRISPR-based at-home diagnostic. Thursday, May 21, 2020 FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry. Thursday, May 21, 2020 Two animal studies out of Harvard showed DNA vaccines against COVID-19 generated similar levels of antibodies that can neutralize the virus as the actual infection does. That will likely fuel enthusiasm for efforts to rapidly develop vaccines against the disease, though the researchers warned there are still several unanswered questions. Wednesday, May 20, 2020 Visits to ambulatory care practices have rebounded slightly since early April but still remain one-third below pre-pandemic levels, a new study found. Wednesday, May 20, 2020 Telehealth provider Amwell has landed $194 million in a series C funding round as the demand for virtual visits surges amid the COVID-19 pandemic. Telehealth companies have attracted attention from investors along with the rising demand for virtual care. Thursday, May 21, 2020 The COVID-19 pandemic has forced companies and organizations worldwide to change courses, and the U.K.’s Vaccines Manufacturing and Innovation Centre is no different. With a new £131 million contribution from the U.K. government, the center aims to both speed up and expand upon its prior ambitions. Thursday, May 21, 2020 GlaxoSmithKline’s consumer products division is teaming up with Jennifer Doudna’s CRISPR-focused outfit Mammoth Biosciences to develop a new COVID-19 diagnostic that would be fast, hand-held and fully disposable. |
|
